Anticoagulation in the Cardiovascular Patient - Heart Course Symposium 2017
Las Vegas, NV US
November 8, 2017
The goal of this activity is to evaluate the clinical trial data
on the use of DOACs, the reversal agents, and educate
practitioners on the safe and effective use of these therapies
in an emergency setting.
Target Audience
Physicians, PAs, NPs, RNs
Learning Objectives
1. Review the latest data on the use of anticoagulant therapy and the risks of major bleeding secondary to DOAC use in patients with cardiovascular disease
2. Evaluate the emerging clinical trial data on the use of reversal agents for DOACs in an emergency
3. Discuss the rapid, safe reversal of DOAC therapy in cardiovascular patients presenting to the Emergency Department
Mandarin Oriental Hotel
752 Las Vegas Boulevard South
Las Vegas, NV
89158
United States
Amer Z. Aldeen, MD, FACEP
Laura J. Bontempo, MD, MEd, FACEP, FAAEM
Available Credit
- 1.00 ACEP
- 1.00 AMA PRA Category 1 Credits™
- 0.00 AOA Category 2A
- 1.00 Certificate of Participation